Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cutaneous lupus erythematosus
(
CLE
) is a heterogeneous autoimmune disease. Different pathogenetic mechanisms, including the accumulation of apoptotic keratinocytes in
CLE
, have been reported. Therefore, we investigated whether
CLE
and other inflammatory skin diseases differ with regard to the epidermal expression of molecules that are crucial for the initiation and regulation of apoptosis. In this study, 241 skin biopsies from patients with
CLE
, psoriasis (PSO), lichen planus (LP) and healthy controls (HCs) were analysed immunohistochemically using the tissue microarray (TMA) technique. The TUNEL assay and anti-activated
caspase-3
antibodies revealed a significant increase of apoptotic keratinocytes in
CLE
lesions compared with HCs. Furthermore, we detected a significant increase in the epidermal expression of CD95 in
CLE
specimens compared with PSO, LP and HCs. These data suggest that the accumulation of apoptotic keratinocytes in
CLE
might be due to the increased epidermal expression of CD95, resulting in increased activity of the extrinsic apoptotic pathway in the disease.
...
PMID:Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray. 2407 35